Editorial: Role of microbiome in diseases diagnostics and therapeutics
Nar Singh Chauhan, Mitali Mukerji, Shashank Gupta
Abstract
The global microbial therapeutics product market size valued at USD 15.94 billion in 2021, is estimated to surpass 30.55 billion USD by 2030 end (https://www. futuremarketinsights.com/reports/microbial-therapeutic-products-market). This reflects the mounting interest of all disciplines besides the medical professionals for accurate and replicable microbiota profiling in diagnostic and therapeutic applications. This area has witnessed a rapid growth mainly due to huge technological advancements as well as our capabilities in understanding microbiota structure, function, their interactions with host in health and diseases Next generation diagnostic solutions based on microbial and microbe-based diagnostic instruments as well as microbial therapeutics promises to be a mainstay in future. For example, microbial therapies that use whole microbiota, an individual microbial member, or microbial metabolites are being exploited to overcome various human illnesses Microbes are pervasive in the environment because of their ability to grow and thrive in a variety of substrates Their growth and proportions could thus reflect the physiological dynamics in spatio-temporal dimensions as well as health and dysbiosis conditions. This issue deals with advancements in this new research frontier and through 24 research articles showcases the experimental studies, novel technological breakthroughs, and case studies that are being carried out to realize the concept of microbiome diagnostics and therapeutic interventions.